Haier Biomedical Showcases Blood Management Innovations at AABB and ISPE 2026
Haier Biomedical is positioning itself as a leader in blood management and pharmaceutical cold storage solutions, as evidenced by its recent presentations at the 2026 AABB Annual Meeting and ISPE Annual and Exposition held in Atlanta and National Harbor respectively. From October 17th to 20th, 2026, industry professionals gathered to explore Haier Biomedical's advancements that focus on temperature control, automation, and digital management to enhance the daily operations of blood transfusion centers and pharmaceutical laboratories.
At the AABB event, Haier Biomedical introduced its integrated solutions for blood management that are designed to support healthcare professionals throughout the plasma collection, storage, and transportation processes. The company’s plasma separator device proves to streamline workflows for staff with its guided setup, automated controls, and adaptive collection monitoring capabilities. Furthermore, electronic logging features significantly ease documentation and traceability – essential in the field of blood management.
To maintain stable storage conditions during routine access, Haier’s blood bank refrigeration solutions offer reliable temperature management, with built-in alarms and backup monitoring capabilities to ensure the integrity of blood products. Additionally, the company's transport refrigeration solutions provide expanded temperature control during transfers between facilities, promoting consistent blood management practices.
During the ISPE meeting, Haier Biomedical showcased its solutions tailored to the interconnected priorities of pharmaceutical laboratories regarding sample protection, energy efficiency, and reliable storage documentation. Their ultra-low temperature freezer employs hydrocarbon refrigerants for precise temperature control while embodying energy-saving technologies, certified by ENERGY STAR for independent verification of energy efficiency. These features, combined with temperature alarms and accessible historical records, aid laboratory staff in daily monitoring of storage conditions and preparing for compliance audits.
The storage of blood derivatives, medications, and biological samples necessitates unwavering reliability in cold storage solutions. Utilizing its expertise in temperature control and automated information management, Haier Biomedical is extending its capabilities through the development of international standards as part of its IEC project. This initiative aims to establish uniform performance criteria and testing methods, assisting manufacturers in assessing equipment designs and helping clients make informed comparisons.
Haier Biomedical's commitment to technological innovation, local service, and international collaboration reaffirms its dedication to supporting clients worldwide. With long-term partnerships, the company aspires to enable life sciences and healthcare institutions to operate more reliably, efficiently, and sustainably. Established in 2005 as a division of Haier Group, Haier Biomedical now operates in over 160 countries and regions, cementing its stance as a top player in the laboratory equipment sector for life sciences according to 2025 sales data from Euromonitor International. The company engages in partnerships with around 80 international organizations, including the World Health Organization and UNICEF, underlining its global impact and commitment to improving healthcare practices.
For more information about Haier Biomedical and its offerings, visit www.haiermedical.com.
Blood Management Innovations
At the AABB event, Haier Biomedical introduced its integrated solutions for blood management that are designed to support healthcare professionals throughout the plasma collection, storage, and transportation processes. The company’s plasma separator device proves to streamline workflows for staff with its guided setup, automated controls, and adaptive collection monitoring capabilities. Furthermore, electronic logging features significantly ease documentation and traceability – essential in the field of blood management.
To maintain stable storage conditions during routine access, Haier’s blood bank refrigeration solutions offer reliable temperature management, with built-in alarms and backup monitoring capabilities to ensure the integrity of blood products. Additionally, the company's transport refrigeration solutions provide expanded temperature control during transfers between facilities, promoting consistent blood management practices.
Pharmaceutical Cold Storage
During the ISPE meeting, Haier Biomedical showcased its solutions tailored to the interconnected priorities of pharmaceutical laboratories regarding sample protection, energy efficiency, and reliable storage documentation. Their ultra-low temperature freezer employs hydrocarbon refrigerants for precise temperature control while embodying energy-saving technologies, certified by ENERGY STAR for independent verification of energy efficiency. These features, combined with temperature alarms and accessible historical records, aid laboratory staff in daily monitoring of storage conditions and preparing for compliance audits.
The storage of blood derivatives, medications, and biological samples necessitates unwavering reliability in cold storage solutions. Utilizing its expertise in temperature control and automated information management, Haier Biomedical is extending its capabilities through the development of international standards as part of its IEC project. This initiative aims to establish uniform performance criteria and testing methods, assisting manufacturers in assessing equipment designs and helping clients make informed comparisons.
Commitment to Innovation and Global Collaboration
Haier Biomedical's commitment to technological innovation, local service, and international collaboration reaffirms its dedication to supporting clients worldwide. With long-term partnerships, the company aspires to enable life sciences and healthcare institutions to operate more reliably, efficiently, and sustainably. Established in 2005 as a division of Haier Group, Haier Biomedical now operates in over 160 countries and regions, cementing its stance as a top player in the laboratory equipment sector for life sciences according to 2025 sales data from Euromonitor International. The company engages in partnerships with around 80 international organizations, including the World Health Organization and UNICEF, underlining its global impact and commitment to improving healthcare practices.
For more information about Haier Biomedical and its offerings, visit www.haiermedical.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.